IL17R inhibitor (Dompe Farmaceutici)

N/A

Report date: 2025/03/20 15:57:18
NME

Base Information

Drug NameIL17R inhibitor (Dompe Farmaceutici)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-17 inhibitors
TargetsInterleukin-17
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDompé Pharmaceutici Spa
China Registration ClassN/A

Develop Information

Active CompaniesDompé Pharmaceutici Spa
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A